Financial Reports and Analysis related to H.C. Wainwright & Co.

•

Form 6-K

•

2025-01-06

Last updated: 4 months ago

BioLineRx Ltd. Reports $1.6M Capital Raise in January 2025 - Form 6-K Filing

BioLineRx Ltd. filed Form 6-K on Jan 6, 2025, detailing a $1.6M capital raise through ADS sales. Key insights on fundraising and regulatory compliance included.

BioLineRx biotechnology capital raise American Depositary Shares H.C. Wainwright & Co.

Posts With Tag H.C. Wainwright & Co.